ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR
AI-Supported Screening Delivering Real-World Clinical Results in Research Studies being Presented at ECR
ScreenPoint Medical Deploys Transpara® Breast AI at Johns Hopkins to Improve Cancer Detection
Transpara implemented for clinical use by key thought leaders in radiology and breast imaging.
ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO
Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO
